Neurocrine
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Neurocrine and other ETFs, options, and stocks.About NBIX
Neurocrine Biosciences, Inc. is a neuroscience-focused, biopharmaceutical company, which engages in the research and development, commercialization, and sale of pharmaceuticals for the treatment of neurological, neuroendocrine, and neuropsychiatric disorders. Its portfolio of products includes treatments for tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia (CAH), and endometriosis and uterine fibroids.
NBIX Key Statistics
Stock Snapshot
With a market cap of 13.14B, Neurocrine(NBIX) trades at $130.96. The stock has a price-to-earnings ratio of 27.49.
On 2026-02-25, Neurocrine(NBIX) stock moved within a range of $128.01 to $131.38. With shares now at $130.96, the stock is trading +2.3% above its intraday low and -0.3% below the session's peak.
Trading activity shows a volume of 963.62K, compared to an average daily volume of 1.61M.
The stock's 52-week range extends from a low of $84.23 to a high of $160.18.
The stock's 52-week range extends from a low of $84.23 to a high of $160.18.
NBIX News
Neurocrine Biosciences (NBIX) is back in focus after reporting fourth quarter and full year 2025 earnings, alongside fresh 2026 sales guidance for INGREZZA and...
Wolfe Research initiated coverage of Neurocrine (NBIX) with an Outperform rating and $160 price target The firm launched coverage of the neuroscience biotech se...
Analyst ratings
87%
of 31 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.